Similar, the PGE2 production of the CD90− population from GBM-48 produced significantly more PGE2 compared to the CD90+ population from the same tumor (mean 213 and 55.5 pg/ml, respectively, p < 0.05; Fig. 4b). This evidence concerns the gene THY1 and glioblastoma.